Summanr The clonogenic growth inhibition. the cell cycle dependence of N4-hexadecyv-I-P-Earabinofuranosylcytosine (NHAC) cytotoxicity and the capability to induce apoptosis in ara-C-sensitive and -resistant HL-60 cells were investigated and compared with arabinofuranosvlcytosine (ara-C). In the clonogenic assay with sensitive HL-60 cells. ara-C was slightly more effective than a liposomal preparation of NHAC. whereas in the resistant cells. NHAC revealed its potency to overcome ara-C resistance, resulting in a 23-fold lower 5000 inhibitory concentration compared with ara-C. Cell cycle dependent cytotoxicity and induction of apoptosis were studied by flow cytometry, using the bromodeoxyuridine-propidium iodide and terminal transferase method respectively-In contrast to ara-C. NHAC exerted no phase-specific toxicity at low concentrations ( <40 AM). At higher concentrations the S-phase-specific toxicity increased. probably resulting from ara-C formed from NHAC_ NHAC induced apoptosis at higher drug concentrations than ara-C. however apoptosis appeared not to be limited to the S-phase cells. Apoptosis occurred in both cell lines within 2-4 h after drug exposure. These results give further evidence that NHAC exerts its cytotoxicity by different mechanisms of action than ara-C and might therefore be active in ara-C-resistant tumours.
Apoptosis is a genetically programmed. active cell death that plays an essential role in the control of normal tissue and tumour cells (Wyllie et al.. 1980) . Cells undergoing apoptosis show a series of typical morphological changes such as chromatin condensation. cell shrinkage, DNA degradation and packaging of cell remnants into apoptotic bodies (Cohen. 1993) . The characteristic event of apoptosis is the activation of an endonuclease with preference to the internucleosomal linker DNA sections. resulting in DNA fragments of multiples of 180-200 bp in size (Arends et al., 1990) . By agarose gel electrophoresis these DNA fragments are displayed in a typical ladder pattern (Kaufmann, 1989) . However, morphologically identified apoptosis is not always accompanied by internucleosomal DNA fragmentation (Cohen et al., 1992) .
The efficacy of different anti-tumour drugs has been associated with their ability to induce apoptosis. Thus. different topoisomerase I or II inhibitors and a variety of diverse cytotoxic agents such as methotrexate, cis-platinum or l-P-D-arabinofuranosylcytosine (ara-C) have been demonstrated to induce endonucleolytic DNA cleavage (Kaufmann, 1989; Gorczyca et al., 1993a) . Although the initiating key element for inducing this cascade leading to cell death is not yet known, it has been shown by different investigators (Fietkau et al.. 1984 : Cavazzana et al., 1988 ) that cells progressing through the S-phase were selectively susceptible to induction of apoptosis when treated with ara-C. The cell cycledependent cytotoxicity of ara-C is caused by the inhibition of DNA synthesis and DNA polymerase activity followed by incorporation of ara-CTP into DNA. causing a block of GI cells at the GI S border. Thus, ara-C is not very efficient in the killing of GI cells (Karon and Shirakawa, 1969) .
M-hexadecyl-l-P-D-arabinofuranosylcytosine (NHAC) is a
new lipophilic derivative of ara-C, one of the most widely used agents for the treatment of acute myelogenous leukaemia. In previous studies, NHAC was shown to exert stronger anti-tumour activity than ara-C in the L1210 mouse leukaemia even at single dose schedules (Schwendener and Schott. 1992; Schwendener et al.. 1995) . Studies about the cellular pharmacologp of NHAC in HL-60. K-562 and U-937 cells resulted in an intracellular half-life, which was up to five times longer than that of ara-C (Horber et al., 1995a,b) . Owing to its lipophilicity, NHAC is predominantly distributed in the cellular membranes. After intravenous administration NHAC is rapidly released from the liposome membranes and transferred to plasma proteins and erythrocytes (Horber et al., 1995c) . In spite of the finding that small amounts of ara-C are formed from NHAC by metabolic processes, we suggested that NHAC is not only a prodrug of ara-C (Horber et al., 1995a) . Thus. NHAC is still cytotoxic in ara-C-resistant HL-60 cells. In other experiments the cytotoxicity of NHAC was shown to be largely independent of the phosphorylation pathway as demonstrated by coincubations with the competitive ara-C phosphorylation inhibitor 2'-deoxycytidine. These results gave evidence that NHAC might be active by yet unknown mechanisms of action. To further elucidate these findings, we studied in the present work the cytotoxicity of NHAC in a clonogenic assay, the cell cycle dependence of the NIHAC cytotoxicity as well as the induction of apoptosis by NHAC in HL-60 and HL-60,, ara-C-resistant cells.
Material and methods
Drugs Ara-C, 5-bromo-2'-deoxyuridine (BrdUrd). Tween 20, bovine serum albumin (BSA), propidium iodide (PI). cacodylic acid, fluoresceinated avidin and RNAse A were purchased from Sigma Chemical (Buchs, Switzerland). Terminal transferase (TdT) and biotin-16-2'-deoxy-uridine-5'-triphosphate (bdUTP) were purchased from Boehringer Mannheim (Rotkreuz, Switzerland). RPMI-1640 medium, minimal essential medium (MEM), Hanks' balanced salt solution (HBSS) and agar gel 2% were purchased from Gibco (Paisley, UK). For all incubations, ara-C was dissolved in phosphate-buffered saline PBS (8 mM sodium phosphate 1.5 mM potassium dihydrogen phosphate, 0.14 M sodium chloride, 2.6 mM potassium chlonrde). NHAC was given in a liposomal formulation as described in the Liposome preparation section. NHAC was synthesised as previously described (Schwendener and Schott, 1992 (Kolla and Studzinski, 1994) . This HL-60/ ara-C subline has been isolated and characterised by Bhalla et al. (1984) . 
Cell cycle distribution anal vsis
The changes in the cell cycle distribution of HL-60 and HL-60 ara-C cells after 24 h incubation with increasing concentrations of ara-C or NHAC are summarised in Table I Basically. the reduction in S-phase cells can be explained by the DNA polymerase inhibition of ara-CTP, which prevents the incorporation of BrdUrd. Thus, after incubation with ara-C or high concentrations of NHAC. early S-phase cells are found after DNA polymerase inhibition in the GI phase population. middle S-phase cells in the S0 phase population and finally late S-phase cells in the G,2M phase population (see also Figure 2 ). Each reduction in S-phase HL-60 cells was therefore followed by an increase in GI, SO and G, M phase cells (Table 1) . SO phase cells are cells which, due to their DNA content belong to the middle S-phase cell fraction, but they do not incorporate BrdUrd into the DNA DNA because of the DNA polymerase inhibition of ara-C (Preisler et al.. 1992) .
In Figure 2 (Table I) , the mechanisms of cytotoxicity of NHAC have to be considered as phase unspecific. At higher drug concentrations, however, a more pronounced effect caused by ara-C formed from metabolised NHAC leads to a specific S-phase cytotoxicity in HL-60 cells.
In the resistant HL-60 ara-C cells ara-C exerted its Sphase-specific toxicity only above 100 gM. At lower drug concentrations, the S-phase cell fraction even increased from 56% to 70% due to a shift of GI phase cells to early S-phase cells (data not shown). NHAC again revealed no phasespecific cytotoxicity at lower drug concentrations, whereas the toxicity at drug concentrations above 100 ILM was S-phase specific. but less pronounced as in the sensitive HL-60 cell line.
The results of the time-dependent cell cycle distribution assays are shown in Table II . Ara-C exerted its S-phasespecific cytotoxicity within the first 2 h of incubation. Likewise, in the HL-60 ara-C-resistant cells. ara-C induced first a slight decrease of the S-phase cell fraction, but after 8 h the phase distribution changed because of a significant increase of early S-phase cells (data not shown). NHAC on the other hand exerted no significant effects on the cell cycle distribution in HL-60 and HL-60 ara-C cells at 50 gM drug concentration.
Quantification of the apoptotic cellfraction
The induction of apoptosis in HL-60 and HL-60 ara-C cells after incubation with increasing concentrations of ara-C or NHAC is summarised in Table III . In contrast to NHAC. ara-C induced apoptosis in a significant fraction of HL-60 cells already at 1 ylM drug concentration, but it was not able to increase the fraction of apoptotic cells to more than 28% during 24 h incubation. This cell population might be represented by the S-phase cell fraction, which was shown to disappear during incubation even with 1 liM ara-C (Table I) .
The well-known property of ara-C to block GI phase cells at the GI/S border hinders or delays therefore the induction of apoptosis in more cells. NHAC on the other hand, was able to induce apoptosis only at concentrations higher than 20 gM. Compared with ara-C, however, NHAC induced apoptosis in more than 50% of the cells at concentrations of 200 JiM and higher, indicating that the induction of apoptosis might not be limited to S-phase cells. Figure 3 illustrates the The fraction of HL-60/ara-C cells undergoing apoptosis after treatment with ara-C was significantly smaller as compared with the sensitive cells. Compared with ara-C, NHAC induced apoptosis in more HL-60/ara-C cells, however, higher drug concentrations compared with the sensitive HL-60 cell line were required (Table III) . This finding would indicate that either the sensitivity for induction of apoptosis in the HL-60/ara-C cell line is lower or that there might exist a synergistic effect between the yet unknown mechanisms of cytotoxicity of NHAC and the ara-C orginating from NHAC.
The time-dependent induction of apoptosis in HL-60 and HL-60/ara-C cells is summarised in Table IV and illustrated by agarose gel electrophoresis in Figure 4 . Apoptosis occurred in HL-60 cells between 2 and 4 h incubation after treatment with ara-C and NHAC. These findings were confirmed by agarose gel electrophoresis. As listed im Table IV, the cell fractions undergoing apoptosis in the HL-60/ara-C cell line were small. Therefore, the DNA ladder pattern was not visible on agarose gels (data not shown). The occurrence of apoptotic cells after NHAC incubation was again detected after 2-4 h incubation, whereas the increase in the apoptotic cell fraction after ara-C treatment was not significant during 24 h incubation.
Previous investigations gave evidence that NHAC exerts cytotoxic mechanisms which are significantly different from those of ara-C. Therefore, to elucidate further these mechanisms of action we studied in the present work the clonogenic toxicity of a liposomal formulation of NHAC, its influence on the cell cycle distnrbution and its ability to induce apoptosis in ara-C-sensitive and resistant HL-60 cells. Since NHAC was found to exert strong cytotoxic activity in a short-time exposure assay (MTT test) (Horber et al., 1995a) it was first investigated if NHAC could also preserve its cytotoxicity in a long-time clonogenic growth inhibition assay lasting 14-21 days after a 24 h drug exposure. Compared with the MIT test, the clonogenic assays were significantly more sensitive with both cell lines. In particular, ara-C had greater effects on clonogenic growth inhibition than on shorttime cytotoxicity. NHAC, on the other hand, was superior to ara-C in the HL-60/ara-C cell line, indicating that this drug is able to overcome ara-C resistance even in a clonogenic growth inhibition assay. It should be emphasised, however, that the results of the studies on cell cycle distribution and induction of apoptosis have to be interpreted in the context of the short-time exposure cytotoxicity assay (Horber et al., 1995a), rather than the clonogenic growth inhibition assay. 25.2 ± 2.8 10.4 1.2 2.4 ± 0.9 5.5 ± 0.2 'HL-60 and HL-60/ara-cells were incubated for 0-24h with 50I1M ara-C or NHAC. Apoptotic cell fraction was determined by flow cytometry using the TdT-PI method. bMean of apoptotic cell fraciuons ± s.d. (%) from two separate experiments.
Fwe 4 Agarose gel eletrophoresis for the detection of endonuceolytic DNA fragmentation in HL-60 cells inducd by incubation with 50 ILM ara-C (Lanes 2-6) or NHAC (Lanes 7-11) for various time periods ranging from 0-8 h. As marker a 123 bp ladder was used (Lanes I and 12).
an increasing ara-C effect, resulting from small concentrations of NHAC metabolised to ara-C and ara-CTP, leads to a specific S-phase toxicity in HL-60 cells. In the resistant HL-60/ara-C cells, NHAC similarly exerted a phaseunspecific toxicity at lower concentrations ranging up to 100 JM, whereas higher drug concentrations led to an increased S-phase toxicity. However, this specific toxicity cannot be explained by ara-C effects originating from NHAC due to the pronounced ara-C resistance of the HL-60/ara-C cell line. Therefore, NHAC itself or one of its yet unklnown metabolites have to be considered as S-phase-specific at high drug concentrations.
The tirm-dependent studies revealed that the S-phase specific inhibition of DNA synthesis occurs within the first two incubation hours. The results from these studies indicate that NHAC exerts its cytotoxicity at lower concentrations not by inhibition of DNA synthesis or DNA polymerase aE, because both mechanisms would lead to specific S-phase toxicity, whereas at high concentrations NHAC might be active in an S-phase-specific manner. For an improved detection of the apoptotic DNA ladder by agarose gel electrophoresis, SYBR Green II was used for staining instead of ethidium bromide. This new fluorescent stain gave better results in the depiction of the ladder pattern and was more sensitive in detecting single-strand DNA, which might occur in apoptotic cells (Bertrand et al., 1991; Yoshida et al., 1993) .
As reported by Gorczyca et al. (1993b) , necrotic cells can not be labelled with b-dUTP, because either the number of DNA strand breaks is low or the 3'-OH termini in these breaks are not accessible to TdT, in contrast to cells undergoing apoptosis. Therefore, the fraction of cells undergoing necrosis cannot be determined using this method, because they cannot be separated from the normal cell population. In addition, the apoptotic cell fractions do not contain any necrotic cells. The determination of apoptotic cell fractions in HL-60 and HL-60/ara-C cells revealed that ara-C is able to induce this mechanism of cell death at much lower concentrations than NHAC, but only to a limited fraction of cells, which represents the S-phase cells, whereas the induction of apoptosis by NHAC is suggested not to be limited to S-phase cells (Tables I and HI) . This limitation of ara-C toxicity to S-phase cells, together with its rapid inactivation, makes it necessary to administer this drug in vivo either continuously for 5 days (Frei et al., 1969) or at high-dose regimens up to 3 gm-2 (Momparler, 1974) . As demonstrated with incubations with high NHAC concentrations in both cell lines, the large number of cells undergoing apoptosis does not only depend on the formation of ara-CTP formed from NHAC. These small amounts of ara-C formed from NHAC are unlikely to induce apoptosis in HL-60/ara-C cells, as shown by the direct incubation with ara-C (Table III) . NHAC itself (or one of its yet unklnown metabolites, with the exception of ara-C) at concentrations > 200 gM is able to induce apoptosis even in HL-60/ara-C-resistant cells.
The comparison of the time-dependent studies of apoptosis induction with the cell cycle distribution clearly shows that the inhibition of DNA synthesis in HL-60 cells occurs within the first 2 h of incubation with ara-C, whereas apoptotic cells appear only after longer lasting drug exposure (Table I) . In HL-60/ara-C cells, NHAC also induced apoptosis 4-24 h after the beginning of incubation, however, at fractions not reaching more than 5.5% of the cell population. Ara-CTP formed from NHAC is unlikely to be responsible for the DNA fragmentation, as shown by direct incubation with ara-C.
In conclusion, our study gives further evidence that NHAC has significntly different cytotoxic mechanisms than ara-C and that this hpophihic derivative is able to overcome ara-C resistance Thus, NHAC exerts at concentrations of 1-40 gM a phase-independent cytotoxicity and is able to induce apoptosis at higher concentrations, which is not restricted to S-phase cells. Together with its highly improved stability against deamination, these properties might explain why NHAC can be administered at lower doses and with singledose schedules to obtain even better anti-tumour effects than ara-C in the murine L1210 leukaemia model (Schwendener and Schott, 1992) .
The exact mechanism of action of NHAC, however, is not yet elucidated and further studies are required. One possible mechanism of action for NHAC, fitting into the findings described here, may consist in an interference of NHAC with signal transduction pathways, which was also described as a mechanism for synthetic anti-tumour alkyl ether lipids (Berggren et al., 1993; Lohmeyer and Workman, 1993; Lohmeyer and Bittman, 1994; Houlihan et al., 1995) . Therefore, further investigations with NHAC will be necessary to clarify its effects on intracellular cell signalling. The chemical structure of NHAC with its highly lipophilic alkyl moiety and the ara-C component may also raise the assumption that its cytotoxic action consists in a combination of mechanisms such as those of the ether lipids and, at a reduced rate, those of ara-C. . :
